News Summary: Court backs FDA in Cytori case

News Summary: Appeals court backs FDA in rejecting fast-track approval for Cytori devices

Associated Press

SHORT CIRCUIT: A federal appeals court said that the Food and Drug Administration made the right call in rejecting fast-track approval of two Cytori Therapeutics Inc. devices used to process adult stem cells.

SPIN DOCTORS: Cytori devices separate adult stem cells from fat tissue with a combination of spinning and chemical reactions. The company appealed an FDA decision in 2011 that said it needed a more rigorous approval process.

REWIND: Cytori has begun a large study it will use to seek traditional FDA approval. It will evaluate stem cell injections as a treatment for patients with heart disease.

Rates

View Comments (0)